Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival | MicrobiomeTrials← Back to trialsNCT03676478
Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival
TERMINATEDNAINTERVENTIONAL
Trial Details
Start: 2019-03-25Est. Completion: 2025-05-25
Enrollment target: 239 participants Locations- University Hospitals Leuven, dept. of Thoracic Surgery, Leuven, Belgium
Other microbiome trials you might be interested in
Borderline Resectable CarcinomaUnresectable CancerEsophageal Squamous Cell Carcinoma (ESCC)Immune Checkpoint InhibitorChemotherapyRadiotherapyTislelizumab
Esophageal cancer (EC) ranks among the leading malignant gastrointestinal tumors globally in terms of both incidence and…
Shantou, ChinaEst. completion Nov 1, 2028
Gastrointestinal NeoplasmsPancreatic NeoplasmsLiver Neoplasm
Oesophageal Cancer
Gastrointestinal Cancer
Pancreatic Cancer
Liver Cancer
Prehabilitation
Cancer Rehabilitation
Major visceral oncologic surgery is associated with high postoperative morbidity, prolonged hospitalization, delayed rec…
Saint Veit Im Pongau, AustriaEst. completion Jun 2027
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial CarcinomasBronchial CarcinomaPleural MesotheliomaHodgkin's LymphomaChronic Lymphocytic LeukemiaFollicular LymphomaMyelomaAL AmyloidosisHepatocarcinomaColorectal CancerEsophageal Squamous Cell CarcinomaHeart CancerCholangiocarcinomaColorectal Adenocarcinoma
Biotherapies are biological (extracted from an organism or living tissue) or biotechnological drugs used in the treatmen…
Angers, FranceEst. completion Jun 2028